Obesity is a complex and multifaceted condition that affects individuals across all age groups, races, and socioeconomic backgrounds, with far-reaching consequences for their health and well-being. It is a prevalent global health issue affecting approximately half the world’s population. A shared mission among healthcare professionals is to equip themselves with the knowledge and skills to address this critical issue effectively. The pharmacotherapy management of obesity is not just about prescribing medications; it is about transforming lives, improving patient outcomes, and helping individuals regain control over their health and quality of life. Currently, the Federal Drug Administration (FDA) has approved nine anti-obesity medications (AOMs) for the short and long-term treatment of obesity. AOMs are recommended with lifestyle change for the therapy of overweight and obesity, following a similar methodology to other chronic disorders.
Pamela Moye, PharmD, BCPS, will breakdown the various facets of obesity management, from understanding the root causes and the epidemiological context to exploring the latest pharmacological interventions. This engaging session will also provide you with insights into practical approaches to develop patient-centered treatment plans, empower patients with the knowledge they need to make informed decisions about their health and promote long-term adherence. There will be an exploration of case studies that challenge decision-making skills and enrich clinical expertise.